AFT expands intravenous Maxigesic distribution in Europe

AFT expands intravenous Maxigesic distribution in Europe
Staff reporters
AFT Pharmaceuticals said it has signed an exclusive licensing agreement for the intravenous version of Maxigesic in eight new European markets.The agreement with Lyon, France-based Aguettant was negotiated and sealed entirely online because of covid-19 restrictions. The intravenous product will now be available in 20 of the 27 European Union states and a total of more than 90 countries worldwide.The tablet form of Maxigesic is licensed in more than 125 countries. The intravenous form of the drug, a combination of paracetamol and ibuprofen, is u...